These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 2973920)

  • 1. [Determination of netilmicin in continuous ambulatory peritoneal dialysis (CAPD): comparison of 3 methods].
    Cavalli G; Zola F; Amprimo MC; Nigra M; Gaido E; Pirotta F
    Clin Ter; 1988 Jan; 124(2):103-8. PubMed ID: 2973920
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of a fluorescence polarization immunoassay of netilmicin in plasma, peritoneal dialysate, and urine with a high-performance liquid chromatographic method.
    Forest JM; Mailhot C; Cartier P; Sirois G
    Ther Drug Monit; 1997 Feb; 19(1):74-8. PubMed ID: 9029751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Netilmicin in the treatment of clinical peritonitis in chronic renal failure patients managed by continuous ambulatory peritoneal dialysis.
    Neale TJ; Malani J; Humble M
    N Z Med J; 1987 Jun; 100(826):374-7. PubMed ID: 3451106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and bactericidal activity of a single daily dose of netilmicin in the treatment of CAPD-associated peritonitis.
    Anding K; Krumme B; Pelz K; Böhler J; Schollmeyer P
    Int J Clin Pharmacol Ther; 1996 Nov; 34(11):465-9. PubMed ID: 8937927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic and intraperitoneal proinflammatory cytokines profiles in patients on chronic peritoneal dialysis.
    Maksić D; Colić M; Stanković-Popović V; Radojević M; Bokonjić D
    Med Pregl; 2007; 60 Suppl 2():53-7. PubMed ID: 18928158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of pharmacokinetics of once daily and continuous intraperitoneal netilmycin in continuous ambulatory peritoneal dialysis patients with peritonitis.
    Kim YW; Jang HJ; Kim YH; Yoon YR; Shin JG; Cha IJ
    Perit Dial Int; 1999; 19 Suppl 2():S291-3. PubMed ID: 10406535
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of glucose concentration on peritoneal inflammatory cytokines in continuous ambulatory peritoneal dialysis patients.
    Sayarlioglu H; Topal C; Sayarlioglu M; Dulger H; Dogan E; Erkoc R
    Mediators Inflamm; 2004 Apr; 13(2):119-21. PubMed ID: 15203553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
    Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
    Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between nitric oxide and oxidative stress in continuous ambulatory peritoneal dialysis patients with peritonitis.
    Duranay M; Yilmaz FM; Yilmaz G; Akay H; Parpucu H; Yücel D
    Scand J Clin Lab Invest; 2007; 67(6):654-60. PubMed ID: 17852815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of surface tension of dialysate depending on its composition in continuous ambulatory peritoneal dialysis.
    Jeleniewicz R; Majdan M; Buraczyńska K; Portala P; Majdan M
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):290-5. PubMed ID: 12898852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Continuous ambulatory peritoneal dialysis. Basic principles].
    Faller B
    Soins; 1991 Jun; (549):14-9. PubMed ID: 1948182
    [No Abstract]   [Full Text] [Related]  

  • 12. Carcinogenic glutamic acid pyrolysis product in the dialysate of uremic patients treated by continuous ambulatory peritoneal dialysis.
    Yanagisawa H; Manabe S; Kanai Y; Wada O
    Clin Nephrol; 1988 Aug; 30(2):73-8. PubMed ID: 3052953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal feeding for the malnourished CAPD patient.
    Soni R
    EDTNA ERCA J; 1997; 23(4):16-8, 21. PubMed ID: 9664017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dialysate CA125 levels in stable peritoneal dialysis patients.
    Okada T; Nakao T; Matsumoto H
    Clin Nephrol; 1999 Jan; 51(1):65-6. PubMed ID: 9988153
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical aspects of continuous ambulatory peritoneal dialysis.
    Grefberg N
    Scand J Urol Nephrol Suppl; 1983; 72():1-46. PubMed ID: 6577582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transport of peritoneal membrane assessed before and after the start of peritoneal dialysis.
    La Milia V; Limardo M; Cavalli A; Crepaldi M; Locatelli F
    Nephrol Dial Transplant; 2009 Sep; 24(9):2894-8. PubMed ID: 19349295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous ambulatory peritoneal dialysis with a high flux membrane. A preliminary report.
    Nolph KD; Moore HL; Prowant B; Twardowski ZJ; Khanna R; Gamboa S; Keshaviah P
    ASAIO J; 1993; 39(3):M566-8. PubMed ID: 8268600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal dialysis.
    Bloe CG
    Prof Nurse; 1990 Apr; 5(7):345-9. PubMed ID: 2343049
    [No Abstract]   [Full Text] [Related]  

  • 19. Is interleukin-6 concentration in the dialysate of continuous ambulatory peritoneal dialysis patients a prognostic parameter in peritonitis?
    Fiedler R; Schneider I; Fischer K; Deuber HJ; Osten B
    Adv Perit Dial; 2001; 17():159-62. PubMed ID: 11510267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY
    Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.